Riskpilot← Back to searchSign inGet full accessPHARMCO II ApS
APSActiveCVR 25202899Tinglykke 4-6Activities of holding companies · NACE 6421Est. 2000— employees
Revenue 2024
DKK -50K
+6% vs 2023
EBITDA margin
100.0%
-6% vs 2023
Equity ratio
77.0%
Financial strength
Net profit 2024
DKK 7,1M
-45% vs 2023
| Revenue | DKK -50K | +6% |
| EBITDA | DKK -50K | -6% |
| Net profit | DKK 7,1M | -45% |
| Total assets | DKK 119,6M | +9% |
| Equity | DKK 92,1M | +8% |
| Employees | — | — |
Legal name
PHARMCO II ApS
CVR number
25202899
Legal form
Anpartsselskab
NACE code
6421 · Activities of holding companies
Founded
4. februar 2000
Share capital
DKK 125.000
Employees
—
VAT registered
No
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktøren.
Company purpose
Selskabets formål er at besidde kapitalandele i andre selskaber samt hermed beslægtet virksomhed.
Address
Tinglykke 4-6
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | — | — | — | — | -19 | -19 | -21 | — | -21 | -18 | -19 | -19 | -19 | 0 | 0 | -47 | -50 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | -19 | -19 | -21 | -169 | -21 | -18 | -19 | -19 | -19 | 0 | 0 | -47 | -50 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | — | — | — | — | — | — | — | — | — | — | — | — | -19 | -19 | -21 | -169 | -21 | -18 | -19 | -19 | -19 | 0 | 0 | -47 | -50 |
| Net financials | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.767 | 3.660 | 1.870 | 0 | 2.507 | 3.053 | 1.495 | 2.034 | 3.078 | 4.763 | -1.726 | 14.330 | 7.888 |
| Profit before tax | — | — | — | — | — | — | — | — | — | — | — | — | 3.748 | 3.641 | 1.850 | -169 | 2.486 | 3.035 | 1.477 | 2.015 | 3.058 | 4.763 | -1.726 | 14.283 | 7.838 |
| Tax | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | 117 | 52 | 31 | -0 | 215 | 250 | -206 | 527 | 287 | 592 | -1 | 1.313 | 741 |
| Net profit | — | — | — | — | — | — | — | — | — | — | — | — | 3.631 | 3.589 | 1.819 | -169 | 2.271 | 2.785 | 1.682 | 1.488 | 2.771 | 4.172 | -1.724 | 12.970 | 7.097 |
| Item | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 48.316 | 51.573 | 53.352 | 32.615 | 57.138 | 60.247 | 69.141 | 73.548 | 69.702 | 73.860 | 95.369 | 109.403 | 119.598 |
| Equity | — | — | — | — | — | — | — | — | — | — | — | — | 47.652 | 51.051 | 52.842 | 125 | 56.699 | 59.493 | 61.178 | 66.887 | 69.651 | 73.823 | 72.096 | 85.089 | 92.124 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.709 | 4.287 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 664 | 522 | 510 | 0 | 439 | 754 | 2.254 | 2.374 | 50 | 37 | 23.272 | 24.314 | 27.474 |
| Total debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 664 | 522 | 510 | 0 | 439 | 754 | 7.963 | 6.661 | 50 | 37 | 23.272 | 24.314 | 27.474 |
EBITDA margin
-5012500.0%
This company
15.8%
Market median
-31724784% vs market
20012024
Equity ratio
77.0%
This company
38.2%
Market median
+102% vs market
20012024
Return on equity
7.7%
This company
18.4%
Market median
-58% vs market
20012024
Net profit margin
709662200.0%
This company
8.1%
Market median
+8761261628% vs market
20012024
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
20012024
Debt / equity
0.30×
This company
0.62×
Market median
+52% vs market
20012024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via CVR / Virk · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via CVR / Virk · Period 2010-05-01 – 2010-12-31
- Annual report 2010Filed via CVR / Virk · Period 2009-05-01 – 2010-04-30
- Annual report 2009Filed via CVR / Virk · Period 2008-05-01 – 2009-04-30
- Annual report 2008Filed via CVR / Virk · Period 2007-05-01 – 2008-04-30
- Annual report 2007Filed via CVR / Virk · Period 2006-05-01 – 2007-04-30
- Annual report 2006Filed via CVR / Virk · Period 2005-05-01 – 2006-04-30
- Annual report 2005Filed via CVR / Virk · Period 2004-05-01 – 2005-04-30
- Annual report 2004Filed via CVR / Virk · Period 2003-05-01 – 2004-04-30
- Annual report 2003Filed via CVR / Virk · Period 2002-05-01 – 2003-04-30
- Annual report 2002Filed via CVR / Virk · Period 2001-05-01 – 2002-04-30
- Annual report 2001Filed via CVR / Virk · Period 2000-02-04 – 2001-04-30
No data on file.
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 66.7% | 66.7% | 2000 | |
PharmCo III ApS | Company | 15.0% | 15.0% | 2020 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
PHARMCO II ApS 
PHARMA NORD EXPORT ApSBoard members of PHARMCO II ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|